Unleashed
Unleashed
Tobias Baer explains why the lack of randomized testing hampers businesses and raises the costs of the COVID-19 pandemic. The lack of randomized testing again and again hampers businesses because it means executives need to make decisions half blind – and Covid-19 is no different, only that in the case of Covid-19, the cost of not doing randomized testing literally might run into the trillions of dollars. Randomized testing is nothing new – and widely considered best practice in…
CATEGORIES
CONTRIBUTOR
tags
Popular Tags
- Aerospace & Defense
- Agriculture
- Automotive
- Biotechnology
- Branding
- Change Management
- Consumer Packaged Goods
- Cosmetics & Personal Care
- Data & Analytics
- Digital Marketing
- Digital Strategy
- Education
- Energy
- Growth Strategy
- Healthcare
- Insurance
- Lean Operations
- Manufacturing
- Media & Entertainment
- Medical Devices
- Mergers & Acquisitions
- Metals & Mining
- NonProfit
- Oil & Gas
- Operations Transformation
- Pharmaceuticals
- Pricing
- Private Equity
- Procurement
- Product Management
- Retail
- Risk Management
- Software
- Supply Chain
- Sustainability
- Talent Management
- Technology
POPULAR POSTS

Welcoming New Mem...
Jun 2, 2023New and Improved ...
Jun 2, 2023Grow Your Busines...
Jun 2, 2023